Identification of serum soluble ST2 receptor as a novel heart failure biomarker

Circulation

Volumn 107, Issue 5, 2003, Pages 721-726

  Weinberg, Ellen O ^a   Shimpo, Masahisa ^a   Hurwitz, Shelley ^a   Tominaga, Shin ichi ^b   Rouleau, Jean Lucien ^c   Lee, Richard T ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Heart failure; Immune system; Natriuretic peptides; Norepinephrine

Indexed keywords

AMLODIPINE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; INTERLEUKIN 1 RECEPTOR; NEUROHORMONE; NORADRENALIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AMLODIPINE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CALCIUM CHANNEL BLOCKERS; CHILD; CHILD, PRESCHOOL; CONTINENTAL POPULATION GROUPS; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; NEUROTRANSMITTER AGENTS; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; SEX FACTORS;

EID: 0037432179     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000047274.66749.FE     Document Type: Article

References (28)

1. Givertz MM. Underlying causes and survival in patients with heart failure. N Engl J Med. 2000;342:1120-1122.
2. Cleland JG, Khand A, Clark A. The heart failure epidemic: exactly how big is it? Eur Heart J. 2001;22:623-626.
3. Lee RT. Functional genomics and cardiovascular drug discovery. Circulation. 2001;104:1441-1146.
4. Weinberg EO, Shimpo M, De Keulenaer GW, et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation. 2002;106:2961-2966.
5. Kuroiwa K, Li H, Tago K, et al. Construction of ELISA system to quantify human ST2 protein in sera of patients. Hybridoma. 2000;19: 151-159.
6. Oshikawa K, Kuroiwa K, Tago K, et al. Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med. 2001;164:277-281.
7. Liang F, Gardner DG. Mechanical strain activates BNP gene transcription through a p38/NF-κB-dependent mechanism. J Clin Invest. 1999;104: 1603-1612.
8. Richards AM, Nicholls MG, Yandle TG, et al. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction: the Christchurch Cardioendocrine Research Group. Heart. 1999;81:114-120.
9. Maeda K, Tsutamoto T, Wada A, et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol. 2000;36:1587-1593.
10. Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000;355:1126-1130.
11. Dhalla KS, Ganguly PK, Rupp H, et al. Measurement of adrenolutin as an oxidation product of catecholamines in plasma. Mol Cell Biochem. 1989; 87:85-92.
12. Moe GW, Rouleau JL, Charbonneau L, et al. Neurohormonal activation in severe heart failure: relations to patient death and the effect of treatment with flosequinan. Am Heart J. 2000;139:587-595.
13. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley; 1989.
14. Anand IS, Florea VG, Fisher L. Surrogate end points in heart failure. J Am Coll Cardiol. 2002;39:1414-1421.
15. Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 2001;37: 386-391.
16. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195-203.
17. Tominaga S. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin I receptor. FEBS Lett. 1989;258:301-304.
18. Yanagisawa K, Takagi T, Tsukamoto T, et al. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett. 1993;318:83-87.
19. Kumar S, Minnich MD, Young PR. ST2/T1 protein functionally birds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1. J Biol Chem. 1995;270: 27905-27913.
20. Gayle MA, Slack JL, Bonnert TP, et al. Cloning of a putative ligand for the T1/ST2 receptor. J Biol Chem. 1996;271:5784-5789.
21. Lohning M, Stroehmann A, Coyle AJ, et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci U S A. 1998;95:6930-6935.
22. Yanagisawa K, Naito Y, Kuroiwa K, et al. The expression of ST2 gene in helper T cells and the binding of ST2 protein to myeloma-derived RPM18226 cells. J Biochem. 1997;121:95-103.
23. Sweet MJ, Leung BP, Kang D, et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol. 2001;166:6633-6639.
24. Kuroiwa K, Arai T, Okazaki H, et al. Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Commun. 2001;284:1104-1108.
25. Oshikawa K, Yanagisawa K, Ohno S, et al. Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Am J Respir Crit Care Med. 2002;165:1005-1009.
26. Prechtel D, Harbeck N, Berger U, et al. Clinical relevance of T1-S, an oncogene-inducible, secreted glycoprotein of the immunoglobulin superfamily, in node-negative breast cancer. Lab Invest. 2001;81:159-165.
27. Schrier RW, Abraham WT. Hormones and hemodynamics in heart failure. N Engl J Med. 1999;341:577-585.
28. Bolger AP, Sharma R, von Haehling S, et al. Effects of interleukin-10 on the production of tumor necrosis factor-α by peripheral blood mononuclear cells from patients with chronic heart failure. Am J Cardiol. 2002;90:384-389.